An experimental program designed to treat Alzheimer’s patients actually reversed memory loss in some study participants, according to recently published results of a small clinical trial by UCLA and Marin’s Buck Institute on Aging. Researchers called the results encouraging, but require further trials. We’ll talk about that study and other recent developments in Alzheimer’s research.
Dale Bredesen, director of the Mary S. Easton Center for Alzheimer's Disease Research at UCLA, and professor at the Buck Institute for Research on Aging in Marin, where he was the founding president and CEO
Lennart Mucke, director of the Gladstone Institute of Neurological Disease
Elizabeth Edgerly, chief program officer for the Alzheimer's Association; head of the Medical and Scientific Advisory Council and runs the annual Researchers Symposium at the Alzheimer's Association